nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aggressive outsourcing yields therapeutic breadth
|
Crossley, Roger |
|
2002 |
|
14 |
p. 756-757 2 p. |
artikel |
2 |
Algal compound could reverse multidrug resistance in cancer
|
Bradley, David |
|
2001 |
|
14 |
p. 706-707 2 p. |
artikel |
3 |
A meeting of minds
|
Gurney, Mark |
|
2001 |
|
14 |
p. 718-720 3 p. |
artikel |
4 |
Antibiotic resistance: can we beat the bugs?
|
Drlica, Karl |
|
2001 |
|
14 |
p. 714-715 2 p. |
artikel |
5 |
A personalised limerick – evidence of esteem?
|
Rowe, Raymond C |
|
2002 |
|
14 |
p. 752-753 2 p. |
artikel |
6 |
Application of formulation technologies in lead candidate selection and optimization
|
Chaubal, Mahesh V. |
|
2004 |
|
14 |
p. 603-609 7 p. |
artikel |
7 |
Bacterial fatty-acid biosynthesis: an antibacterial drug target waiting to be exploited
|
Heath, Richard J. |
|
2001 |
|
14 |
p. 715- 1 p. |
artikel |
8 |
Bacterial Resistance to Antimicrobials
|
Heinemann, Jack A |
|
2002 |
|
14 |
p. 758- 1 p. |
artikel |
9 |
Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease
|
Bodor, Nicholas |
|
2002 |
|
14 |
p. 766-774 9 p. |
artikel |
10 |
By gum – a buccal delivery system
|
Rowe, Raymond C |
|
2003 |
|
14 |
p. 617-618 2 p. |
artikel |
11 |
Cambridge: Europe's leading location for biotechnology
|
Jeanette, Walker |
|
2005 |
|
14 |
p. 956-959 4 p. |
artikel |
12 |
Cancer prevention a step nearer
|
Scott, Ewan |
|
2005 |
|
14 |
p. 950-951 2 p. |
artikel |
13 |
Cervical cancer vaccines available in 2007
|
Mariam, Andrawiss |
|
2005 |
|
14 |
p. 949-950 2 p. |
artikel |
14 |
Computational approaches to the understanding of ADMET properties and problems
|
Modi, Sandeep |
|
2003 |
|
14 |
p. 621-623 3 p. |
artikel |
15 |
Could anti-inflammatory medicines treat viral eye diseases?
|
Whelan, Jo |
|
2001 |
|
14 |
p. 703-704 2 p. |
artikel |
16 |
Delivering peptides and proteins to tumors
|
Sehgal, Anil |
|
2003 |
|
14 |
p. 619- 1 p. |
artikel |
17 |
Delivery options for contraceptives
|
Sitruk-Ware, Regine |
|
2005 |
|
14 |
p. 977-985 9 p. |
artikel |
18 |
Developments in microarray technologies
|
Howbrook, David N. |
|
2003 |
|
14 |
p. 642-651 10 p. |
artikel |
19 |
DNA dumbbells: decoys for gene-regulatory proteins
|
Demidov, Vadim V. |
|
2001 |
|
14 |
p. 749-750 2 p. |
artikel |
20 |
Drug discoverers – you need us – Reply
|
Shultis, Kenton |
|
2001 |
|
14 |
p. 716- 1 p. |
artikel |
21 |
Dumped drugs could prevent HIV
|
Clayton, Julie |
|
2002 |
|
14 |
p. 746-747 2 p. |
artikel |
22 |
Ebola glycoprotein: the key to successful gene therapy?
|
Sutherland, Stephani |
|
2003 |
|
14 |
p. 609-610 2 p. |
artikel |
23 |
Efficacy of the anti-angiogenic approach to solid tumors
|
Reff, M. |
|
2001 |
|
14 |
p. 716-717 2 p. |
artikel |
24 |
European patent law and ethics
|
Plomer, Aurora |
|
2005 |
|
14 |
p. 947-948 2 p. |
artikel |
25 |
Fragment-based lead discovery: leads by design
|
Carr, Robin A.E. |
|
2005 |
|
14 |
p. 987-992 6 p. |
artikel |
26 |
Glia emerge as pain therapy targets
|
Sutherland, Stephani |
|
2004 |
|
14 |
p. 588- 1 p. |
artikel |
27 |
Highly sensitive fluorescence detection technology currently available for HTS
|
Eggeling, Christian |
|
2003 |
|
14 |
p. 632-641 10 p. |
artikel |
28 |
High-throughput protein expression for the post-genomic era
|
Chambers, Stephen P |
|
2002 |
|
14 |
p. 759-765 7 p. |
artikel |
29 |
Holographic imaging of live tumours
|
Habeck, Martina |
|
2002 |
|
14 |
p. 744-745 2 p. |
artikel |
30 |
Imaging in oncology
|
Waterton, John C. |
|
2004 |
|
14 |
p. 593-594 2 p. |
artikel |
31 |
John Anson of GE Healthcare
|
Carney, Steve |
|
2005 |
|
14 |
p. 952-955 4 p. |
artikel |
32 |
Keynote review: Recent advances in biomarkers for cancer diagnosis and treatment
|
Manne, Upender |
|
2005 |
|
14 |
p. 965-976 12 p. |
artikel |
33 |
LC–NMR–MS in drug discovery
|
Corcoran, Olivia |
|
2003 |
|
14 |
p. 624-631 8 p. |
artikel |
34 |
Memorable mnemonics
|
Rowe, Raymond C. |
|
2005 |
|
14 |
p. 962-963 2 p. |
artikel |
35 |
Metabolic ménages à trois: what does it mean for drug design?
|
Jones, Jeffrey P. |
|
2004 |
|
14 |
p. 592- 1 p. |
artikel |
36 |
Molecular imaging: what picture does it paint for future oncology?
|
Price, Pat |
|
2002 |
|
14 |
p. 741-743 3 p. |
artikel |
37 |
Molecules
|
Westwell, Andrew D |
|
2003 |
|
14 |
p. 652-654 3 p. |
artikel |
38 |
Monitor – Biology
|
Cheung, Herman H. |
|
2004 |
|
14 |
p. 621-622 2 p. |
artikel |
39 |
Monitor – biology
|
Cheung, Herman H. |
|
2005 |
|
14 |
p. 1008-1009 2 p. |
artikel |
40 |
Monitor – Business
|
Barton, Samantha |
|
2004 |
|
14 |
p. 623- 1 p. |
artikel |
41 |
Monitor – Chemistry
|
Barlocco, Daniela |
|
2004 |
|
14 |
p. 619-620 2 p. |
artikel |
42 |
Monitor – chemistry
|
Barlocco, Daniela |
|
2005 |
|
14 |
p. 1008- 1 p. |
artikel |
43 |
Monitor: molecules and profiles
|
Langston, Steven |
|
2001 |
|
14 |
p. 745-747 3 p. |
artikel |
44 |
Monitor – People
|
Barton, Samantha |
|
2004 |
|
14 |
p. 624- 1 p. |
artikel |
45 |
Muscle-based gene therapy and tissue engineering for the musculoskeletal system
|
Wright, Vonda J. |
|
2001 |
|
14 |
p. 728-733 6 p. |
artikel |
46 |
New cannabinoid for multiple sclerosis
|
Whelan, Jo |
|
2002 |
|
14 |
p. 745-746 2 p. |
artikel |
47 |
New mode of intervention in sepsis treatment
|
Foubister, Vida |
|
2003 |
|
14 |
p. 610-612 3 p. |
artikel |
48 |
News in Brief
|
Brown, Matt |
|
2003 |
|
14 |
p. 613-615 3 p. |
artikel |
49 |
News in brief
|
Clough, J |
|
2002 |
|
14 |
p. 748-750 3 p. |
artikel |
50 |
News in brief
|
Berry, Suzanne |
|
2001 |
|
14 |
p. 708-710 3 p. |
artikel |
51 |
Novel antitumour molecules
|
Westwell, Andrew D. |
|
2002 |
|
14 |
p. 780-783 4 p. |
artikel |
52 |
Novel antiviral molecules
|
Walker, Michael A |
|
2002 |
|
14 |
p. 779-780 2 p. |
artikel |
53 |
Novel antiviral molecules
|
Walker, Michael A. |
|
2001 |
|
14 |
p. 747-749 3 p. |
artikel |
54 |
Ontologies and semantic data integration
|
Gardner, Stephen P. |
|
2005 |
|
14 |
p. 1001-1007 7 p. |
artikel |
55 |
Oral peptide and protein delivery: unfulfilled promises?
|
Shen, Wei-Chiang |
|
2003 |
|
14 |
p. 607-608 2 p. |
artikel |
56 |
Organotypic cultures as tools for functional screening in the CNS
|
Sundstrom, Lars |
|
2005 |
|
14 |
p. 993-1000 8 p. |
artikel |
57 |
People
|
Tranter, D |
|
2002 |
|
14 |
p. 751- 1 p. |
artikel |
58 |
People
|
Clough, Joanne |
|
2003 |
|
14 |
p. 616- 1 p. |
artikel |
59 |
People
|
Lawrence, Rebecca N. |
|
2001 |
|
14 |
p. 711- 1 p. |
artikel |
60 |
Phage display for target-based antibacterial drug discovery
|
Christensen, Dale J |
|
2001 |
|
14 |
p. 721-727 7 p. |
artikel |
61 |
Progress towards better understanding and treatment of major psychiatric illnesses
|
Bryan, Roth |
|
2005 |
|
14 |
p. 960-962 3 p. |
artikel |
62 |
Prostate cancer target ‘moveable’
|
Vida, Foubister |
|
2005 |
|
14 |
p. 951-952 2 p. |
artikel |
63 |
Protein crystallization – is it rocket science?
|
DeLucas, Lawrence J |
|
2001 |
|
14 |
p. 734-744 11 p. |
artikel |
64 |
Publish or perish
|
Rowe, Raymond C. |
|
2004 |
|
14 |
p. 590-591 2 p. |
artikel |
65 |
Refolding mutant p53: a simple way to resolve a complex problem?
|
Zeimet, Alain G. |
|
2003 |
|
14 |
p. 620- 1 p. |
artikel |
66 |
Reliable high-throughput functional screening with 3-FABS
|
Dalvit, Claudio |
|
2004 |
|
14 |
p. 595-602 8 p. |
artikel |
67 |
Science with a smile – the limerick
|
Rowe, Raymond C |
|
2001 |
|
14 |
p. 712-713 2 p. |
artikel |
68 |
Solving insoluble drug delivery
|
Nicholls, Henry |
|
2003 |
|
14 |
p. 612- 1 p. |
artikel |
69 |
Sterols and sterolins: new drugs for the immune system?
|
Bouic, Patrick J.D |
|
2002 |
|
14 |
p. 775-778 4 p. |
artikel |
70 |
The double-edged cytokine sword of non-viral gene targeting to tumors
|
Spack, Edward G |
|
2002 |
|
14 |
p. 754-755 2 p. |
artikel |
71 |
The importance of predictive ADME simulation
|
Dickins, Maurice |
|
2002 |
|
14 |
p. 755-756 2 p. |
artikel |
72 |
The new generation of patch-clamp equipment
|
Netzer, Rainer |
|
2004 |
|
14 |
p. 593- 1 p. |
artikel |
73 |
The rise and fall of Viagra
|
Fricker, Janet |
|
2001 |
|
14 |
p. 704-706 3 p. |
artikel |
74 |
The story of gefitinib, an EGFR kinase that works in lung cancer
|
Golsteyn, Roy M. |
|
2004 |
|
14 |
p. 587- 1 p. |
artikel |
75 |
Up close and personal: anti-herpes drug development
|
Bradbury, Jane |
|
2004 |
|
14 |
p. 589- 1 p. |
artikel |
76 |
Using germ-line genetic variation to investigate and treat cancer
|
Savage, Sharon A. |
|
2004 |
|
14 |
p. 610-618 9 p. |
artikel |